NCT02039986View on ClinicalTrials.gov

Ivacaftor (Kalydeco) and Insulin in Cystic Fibrosis (CF)

CompletedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

January 6, 2014

Primary Completion Date

October 11, 2016

Study Completion Date

October 11, 2016

Conditions
Cystic Fibrosis Related DiabetesCystic Fibrosis
Trial Locations (1)

19104

The Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
lead

Children's Hospital of Philadelphia

OTHER

NCT02039986 - Ivacaftor (Kalydeco) and Insulin in Cystic Fibrosis (CF) | Biotech Hunter | Biotech Hunter